PHARMACITY LIMITED

Company number 09424995 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£2m -£1m £0 £1m £2m £3m 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £1,919,734 Total assets 2017: £1,940,251 Total assets 2018: £1,970,768 Total assets 2019: £1,952,786 Total assets 2020: £1,952,098 Total assets 2021: £1,949,572 Total assets 2022: £2,055,945 Total assets 2023: £2,044,385 Total assets 2024: £1,911,956 Total assets 2025: £1,913,207 Total assets Net assets 2016: £592 Net assets 2017: £2,720 Net assets 2018: £165,135 Net assets 2019: £248,376 Net assets 2020: £335,775 Net assets 2021: £523,173 Net assets 2023: £669,197 Net assets 2024: £743,114 Net assets 2025: £855,166 Net assets Total liabilities 2016: -£1,678,593 Total liabilities 2017: -£1,595,428 Total liabilities 2018: -£1,449,781 Total liabilities 2019: -£1,614,159 Total liabilities 2020: -£1,522,443 Total liabilities 2021: -£1,332,519 Total liabilities 2022: -£1,362,279 Total liabilities 2023: -£1,270,327 Total liabilities 2024: -£1,048,484 Total liabilities 2025: -£925,232 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 0 1 2024 2025 2024: 1 2025: 1

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 11 years

Latest accounts (2025-08-31): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-08-31 £1,913,207 -£925,232 £855,166 1
2024-08-31 £1,911,956 -£1,048,484 £743,114 1
2023-08-31 £2,044,385 -£1,270,327 £669,197
2022-08-31 £2,055,945 -£1,362,279
2021-08-31 £1,949,572 -£1,332,519 £523,173
2020-08-31 £1,952,098 -£1,522,443 £335,775
2019-08-31 £1,952,786 -£1,614,159 £248,376
2018-08-31 £1,970,768 -£1,449,781 £165,135
2017-08-31 £1,940,251 -£1,595,428 £2,720
2016-08-31 £1,919,734 -£1,678,593 £592
2015-08-31 -£1,977,771 £109,492

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.